Literature DB >> 9740571

Late onset interstitial nephritis associated with mesalazine treatment.

J Popoola1, A F Muller, L Pollock, P O'Donnell, P Carmichael, P Stevens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9740571      PMCID： PMC1113907          DOI： 10.1136/bmj.317.7161.795

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Acute interstitial nephritis due to 5-aminosalicylic acid.

Authors:  R P Mehta
Journal:  CMAJ       Date:  1990-11-15       Impact factor: 8.262

Review 2.  Choosing an oral 5-aminosalicylic acid preparation for ulcerative colitis.

Authors: 
Journal:  Drug Ther Bull       Date:  1992-06-22

3.  Mesalazine-associated interstitial nephritis: twice in the same patient.

Authors:  L Manenti; A De Rosa; C Buzio
Journal:  Nephrol Dial Transplant       Date:  1997-09       Impact factor: 5.992

Review 4.  5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: is there a link?

Authors:  M E De Broe; J C Stolear; E J Nouwen; M M Elseviers
Journal:  Nephrol Dial Transplant       Date:  1997-09       Impact factor: 5.992

5.  Mesalazine-associated interstitial nephritis.

Authors:  M J World; P E Stevens; M A Ashton; D J Rainford
Journal:  Nephrol Dial Transplant       Date:  1996-04       Impact factor: 5.992

6.  5-Aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease.

Authors:  J Hämling; A Raedler; U Helmchen; S Schreiber
Journal:  Digestion       Date:  1997       Impact factor: 3.216

7.  Interstitial nephritis associated with 5-aminosalicylic acid.

Authors:  T Witte; C J Olbricht; K M Koch
Journal:  Nephron       Date:  1994       Impact factor: 2.847

8.  [Tubulointerstitial nephritis caused by mesalazine (5-ASA) agents].

Authors:  T J Smilde; F J van Liebergen; M I Koolen; P G Gerlag; K J Assmann; J H Berden
Journal:  Ned Tijdschr Geneeskd       Date:  1994-12-17

9.  Mesalazine induced interstitial nephritis.

Authors:  P J Thuluvath; M Ninkovic; J Calam; M Anderson
Journal:  Gut       Date:  1994-10       Impact factor: 23.059
  9 in total
  8 in total

1.  Chronic tubulointerstitial nephritis induced by 5-aminosalicylate in an ulcerative colitis patient: a rare but serious adverse event.

Authors:  Pedro Magalhães-Costa; Leopoldo Matos; Cristina Chagas
Journal:  BMJ Case Rep       Date:  2015-05-02

2.  Do gastroenterologists monitor their patients taking 5-amino-salicylates following initiation of treatment.

Authors:  N Siddique; C Farmer; A F Muller
Journal:  Frontline Gastroenterol       Date:  2014-06-04

3.  Acute interstitial nephritis associated with ulcerative colitis.

Authors:  Hirobumi Tokuyama; Shu Wakino; Konosuke Konishi; Akinori Hashiguchi; Koichi Hayashi; Hiroshi Itoh
Journal:  Clin Exp Nephrol       Date:  2010-05-25       Impact factor: 2.801

4.  Interstitial nephritis from mesalazine: case report and literature review.

Authors:  Lois J Arend; James E Springate
Journal:  Pediatr Nephrol       Date:  2004-03-09       Impact factor: 3.714

5.  Renal effects of long-term treatment with 5-aminosalicylic acid.

Authors:  H Patel; A Barr; K N Jeejeebhoy
Journal:  Can J Gastroenterol       Date:  2009-03       Impact factor: 3.522

6.  Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn's disease.

Authors:  Glen A Doherty; Mark A Peppercorn
Journal:  Clin Exp Gastroenterol       Date:  2009-12-08

Review 7.  Oral delayed-release mesalazine: a review of its use in ulcerative colitis and Crohn's disease.

Authors:  A Prakash; A Markham
Journal:  Drugs       Date:  1999-03       Impact factor: 11.431

Review 8.  5-ASA induced interstitial nephritis in patients with inflammatory bowel disease: a systematic review.

Authors:  James G Moss; Christopher M Parry; Richard C L Holt; Stephen J McWilliam
Journal:  Eur J Med Res       Date:  2022-04-29       Impact factor: 4.981
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.